Supplementary Material for: Predictive Value of Endobronchial Ultrasound Strain Elastography in Mediastinal Lymph Node Staging: The E-Predict Multicenter Study Results
收藏DataCite Commons2025-06-01 更新2024-07-28 收录
下载链接:
https://karger.figshare.com/articles/Supplementary_Material_for_Predictive_Value_of_Endobronchial_Ultrasound_Strain_Elastography_in_Mediastinal_Lymph_Node_Staging_The_E-Predict_Multicenter_Study_Results/12416246/1
下载链接
链接失效反馈官方服务:
资源简介:
<b><i>Background:</i></b> Systematic assessment of lymph node status by endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is indicated in (suspected) lung cancer. Sampling is herein guided by nodal size and FDG-PET characteristics. Ultrasound strain elastography (SE) might further improve risk stratification. By imaging tissue deformation over time, SE computes relative tissue strain. In several tissues, a lower strain (deformation) has been associated with a higher likelihood of malignancy. <b><i>Objectives:</i></b> To assess if EBUS-SE can independently help predict malignancy, and when combined with size and FDG uptake information. <b><i>Methods:</i></b> This multicenter (<i>n</i> = 5 centers) prospective trial included patients with suspected or proven lung cancer using a standardized measurement protocol. Cytopathology combined with surgery or follow-up imaging (>6 months) were used as reference standard. <b><i>Results:</i></b> Between June 2016 and July 2018, 327 patients and 525 lymph nodes were included (mean size 12.3 mm, malignancy prevalence 0.48). EBUS-SE had an overall AUC of 0.77. A mean strain <115 (range 0–255) showed 90% sensitivity, 43% specificity, 60% positive predictive value, and 82% negative predictive value. Combining EBUS-SE (<115) with size (<8 mm) and FDG-PET information into a risk stratification algorithm increased the accuracy. Combining size and SE showed that the 48% a priori chance of malignancy changed to 11 and 70% in double negative or positive nodes, respectively. In the subset where FDG-PET was available (<i>n</i> = 370), triple negative and positive nodes went from a 42% a priori chance of malignancy to 9 and 73%, respectively. <b><i>Conclusions:</i></b> EBUS-SE can help predict lymph node malignancy and may be useful for risk stratification when combined with size and PET information.
提供机构:
Karger Publishers
创建时间:
2020-06-03



